Enabling advances in medicine.
凭借我们对科学严谨性的热忱和数十年来的临床试验经验,我们可以迅捷而轻松地化解障碍。我们相信,通过创建多样化和包容性的临床试验,消除参与过程中的各种差距,可以促进健康公平。 We are problem-solvers and creative thinkers, committed to opening the doors between promising ideas and proven therapies.
A transformative force in clinical trial research, design and device development.
空格
空格
As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.
We are listening to what companies want from their drug development and device partners.我们倾听并了解CRO行业在哪些方面仍有提升空间。 A breakthrough environment with the agility to promote and respond to changes in trial design, development and delivery continues to be an imperative.我们正在采取行动。我们正在打造Fortrea,并与之一起描绘新的蓝图,为客户提供卓越的服务,从而无愧于我们在科学专业领域所享有的声誉。
我们相信合作伙伴关系的力量可以激发深入见解,创造新的可能性。 We offer our customers a tailored approach to clinical trial solutions through the use of three delivery models: full service, functional service providers or a hybrid approach. Our team of more than 19,000 professionals partners with emerging and large biopharma and medical device and diagnostic companies to support operations and drive healthcare innovation in nearly 100 countries.
“Fortrea品牌的首次亮相是一个决定性时刻,因为我们致力于打造一个领先的专业CRO。我们创造了这个名字,以传达我们专注于推动创新并为全球患者开发可以挽救生命的治疗方法。它体现了我们30年的发展历史和我们的新身份,因为我们对Fortrea的定位是抓住我们面前的巨大机遇,并为我们所有的利益相关者创造价值.”
徕博科临床研发业务总裁兼首席执行官,以及Fortrea未来的首席执行官和董事会主席。
您是刚开始工作并希望建立自己职业生涯的年轻专业人士?Fortrea可以成为实现这一目标的地方。